Page last updated: 2024-10-25

clioquinol and Epidermolysis Bullosa

clioquinol has been researched along with Epidermolysis Bullosa in 1 studies

Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.

Epidermolysis Bullosa: Group of genetically determined disorders characterized by the blistering of skin and mucosae. There are four major forms: acquired, simple, junctional, and dystrophic. Each of the latter three has several varieties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biedrzynska, B1
Blaszczyk, E1
Stencel-Citowicka, E1

Other Studies

1 other study available for clioquinol and Epidermolysis Bullosa

ArticleYear
[Case of acrodermatitis enteropathica in an infant].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1975, Mar-15, Volume: 28, Issue:6

    Topics: Acrodermatitis; Clioquinol; Diagnostic Errors; Epidermolysis Bullosa; Female; Gastrointestinal Disea

1975